Several meta‐analyses, involving substantial patient cohorts ranging from 7541 to 11 444 individuals, have encountered methodological limitations such as the inclusion of heterogeneous NSCLC populations (excluding patients from Africa and Latin America), and the utilization of various antibodies, staining techniques, and threshold values for defining PD‐L1 expression.14, 15, 16. Here, CD274 is linked to non-small cell lung carcinoma.